NewsFDASaturday, May 10, 2025 · May 10, 2025
Skyclarys Approved for Friedreich Ataxia
WHY IT MATTERS
First-ever approved treatment for Friedreich ataxia after decades with no therapy.
The FDA approved omaveloxolone (Skyclarys) as the first treatment for Friedreich ataxia, a rare inherited neurodegenerative disease.
Related conditions
Related news
FDA
FDA Approves XTORO
XTORO (FINAFLOXACIN) received FDA approval.…
FDA
FDA Approves IOPIDINE
IOPIDINE (APRACLONIDINE HYDROCHLORIDE) received FDA approval.…
FDA
FDA Approves SABRIL
SABRIL (VIGABATRIN) received FDA approval.…
FDA
FDA Approves IOPIDINE
IOPIDINE (APRACLONIDINE HYDROCHLORIDE) received FDA approval.…